{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:21Z","timestamp":1790727321657,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u015ei\u015fli Hamidiye Etfal Teaching and Research Hospital","award":["2015\/37"],"award-info":[{"award-number":["2015\/37"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pnpbp.2017.04.025","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T23:02:24Z","timestamp":1492902144000},"page":"322-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"PC","title":["Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: An rTMS study"],"prefix":"10.1016","volume":"80","author":[{"given":"Efruz Pirdo\u011fan","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Gen\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihriban","family":"Dalk\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece T\u00fcrkyilmaz","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Akil","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay\u0131han O\u011fuz","family":"Karamustafal\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.04.025_bb0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0447.2006.00932.x","article-title":"Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up","volume":"115","author":"Airaksinen","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/comp.2001.19756","article-title":"Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale","volume":"42","author":"Akdemir","year":"2001","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2005.04.024","article-title":"Executive dysfunction and the course of geriatric depression","volume":"58","author":"Alexopoulos","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0030","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0033291713000512","article-title":"Response, remission and dropout rates following high frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials","volume":"44","author":"Berlim","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1532-5415.2000.tb02603.x","article-title":"Cognitive decline is associated with systemic oxidative stress - the EVA study","volume":"48","author":"Berr","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00406-005-0577-7","article-title":"Executive function improvement upon remission of recurrent unipolar depression","volume":"255","author":"Biringer","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0055","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/1871527313666141130203823","article-title":"Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review","volume":"13","author":"Bortolato","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tips.2005.06.005","article-title":"Thioredoxin: friend or foe in human disease?","volume":"26","author":"Burke-Gaffney","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1567205011310040003","article-title":"Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease","volume":"10","author":"Cervellati","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psychres.2012.10.018","article-title":"Increased oxidative stress in patients with depression and its relationship to treatment","volume":"206","author":"Chung","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3233\/JAD-150679","article-title":"Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment","volume":"49","author":"Chung","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neurobiolaging.2008.05.009","article-title":"Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase=catalase mimetics in aged mice","volume":"31","author":"Clausen","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3171\/jns.2003.99.6.1063","article-title":"Repetitive transcranial magnetic stimulation for protection against delayed neuronal death induced by transient ischemia","volume":"99","author":"Fujiki","year":"2003","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0105","doi-asserted-by":"crossref","unstructured":"Fukui, K., Omoi, N.O., Hayasaka, T., Shinnkai, T., Suzuki, S., Abe, K., Urano, S., 2002. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann. N.Y. Acad. Sci. 959, 275\u201384.","DOI":"10.1111\/j.1749-6632.2002.tb02099.x"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.brs.2012.06.006","article-title":"An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study","volume":"6","author":"Furtado","year":"2012","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1734-1140(09)70084-2","article-title":"Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment","volume":"61","author":"Ga\u0142ecki","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0120","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.12659\/MSM.893176","article-title":"Mechanisms underlying neurocognitive dysfunctions in recurrent major depression","volume":"21","author":"Ga\u0142ecki","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/pcn.12244","article-title":"Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment","volume":"69","author":"Genc","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.09.026.2009","article-title":"Cognitive functioning in major depression-a summary","volume":"3","author":"Hammar","year":"2009","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","article-title":"Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment","volume":"38","author":"Herken","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1179\/016164105X39897","article-title":"Influence of repetitive transcranial magnetic stimulation on disease severity and oxidative stress markers in the cerebrospinal fluid of patients with spinocerabellar degeneration","volume":"27","author":"Ihara","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","article-title":"Neurocognitive deficits and disability in major depressive disorder","volume":"145","author":"Jaeger","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0150","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0155","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.pnpbp.2011.03.021","article-title":"Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study","volume":"35","author":"Kotan","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0160","first-page":"991","article-title":"Redox regulation of cell growth and cell death","volume":"384","author":"Kwon","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/070674371405901206","article-title":"Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment","volume":"59","author":"Lam","year":"2014","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0170","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","article-title":"Inflammation, depression and dementia: are they connected?","volume":"32","author":"Leonard","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0175","doi-asserted-by":"crossref","first-page":"24438","DOI":"10.3390\/ijms141224438","article-title":"Oxidative stress and neurodegenerative disorders","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0180","doi-asserted-by":"crossref","first-page":"e0138904","DOI":"10.1371\/journal.pone.0138904","article-title":"A meta-analysis of oxidative stress markers in depression","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362841","article-title":"Lymphocyte levels of redox sensitive transcription factors and antioxidative enzymes as indicators of pro-oxidative state in depressive patients","volume":"70","author":"Lukic","year":"2014","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1073\/pnas.0337481100","article-title":"Course of illness, hippocampal function, and hippocampal volume in major depression","volume":"100","author":"MacQueen","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0195","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","article-title":"Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression","volume":"36","author":"Maes","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archneur.63.1.38","article-title":"Neuropathologic substrate of mild cognitive impairment","volume":"63","author":"Markesbery","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1192\/bjp.182.6.480","article-title":"Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis","volume":"182","author":"Martin","year":"2003","journal-title":"Brit. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1388-2457(03)00046-4","article-title":"Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression","volume":"114","author":"Martis","year":"2003","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0220","series-title":"Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities, United Kingdom","first-page":"15","article-title":"Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder","author":"Maruff","year":"2016"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0225","first-page":"2479","article-title":"A meta-analysis of lipid peroxidation markers in major depression","volume":"11","author":"Mazereeuw","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","article-title":"The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project","volume":"56","author":"McIntyre","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0235","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/WNL.58.8.1288","article-title":"Improved executive functioning following repetitive transcranial magnetic stimulation","volume":"58","author":"Moser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0240","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1002\/hbm.23235","article-title":"Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder","volume":"37","author":"Murrough","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/WNN.0000000000000031","article-title":"Cognitive effects of treatment of depression with repetitive transcranial magnetic stimulation","volume":"27","author":"Nadeau","year":"2014","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1096\/fj.02-0448fje","article-title":"Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress","volume":"17","author":"Nagai","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0255","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0260","series-title":"Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary","author":"National Academies of Sciences, Engineering, and Medicine","year":"2015"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/acps.12570","article-title":"The interrelationship between attentional and executive deficits in major depressive disorder","volume":"134","author":"Nilsson","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0270","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0275","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.pnpbp.2011.03.012","article-title":"Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia","volume":"35","author":"Owe-Larsson","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Ozcan","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(99)00092-X","article-title":"Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS","volume":"88","author":"Padberg","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PSY.0000000000000009","article-title":"Depression and oxidative stress: results from a meta-analysis of observational studies","volume":"76","author":"Palta","year":"2014","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0295","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum?","volume":"18","author":"Panza","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jad.2011.12.006","article-title":"High-frequency rTMS treatment increases white matter FA in the left middle frontal gyrus in young patients with treatment-resistant depression","volume":"136","author":"Peng","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/npp.2010.166","article-title":"Frontocingulate dysfunction in depression: toward biomarkers of treatment response","volume":"36","author":"Pizzagalli","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0310","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1046\/j.1460-9568.1999.00747.x","article-title":"Repetetive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo","volume":"11","author":"Post","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0315","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systemic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0320","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10571-014-0074-5","article-title":"Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability","volume":"34","author":"Rodrigues","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0325","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/JGP.0b013e3181c53487","article-title":"Depressive symptoms predict incident cognitive impairment in cognitive healthy older women","volume":"18","author":"Rosenberg","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0330","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hup.829","article-title":"Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative\u2013antioxidative systems","volume":"22","author":"Sarandol","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.02.030","article-title":"Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology","volume":"42","author":"Scheff","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0345","first-page":"166","article-title":"Power of discrimination of Montreal Cognitive Assessment (MoCA) Scale in Turkish Patients with Mild Cognitive Impairment and Alzheimer's Disease","volume":"13","author":"Selekler","year":"2010","journal-title":"Turkish J. Geriatrics"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0350","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fpsyg.2014.00772","article-title":"What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults","volume":"5","author":"Shao","year":"2014","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0355","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00124509-200112000-00005","article-title":"Lack of adverse cognitive effects of 1 and 20Hz repetetive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression","volume":"17","author":"Speer","year":"2001","journal-title":"J. ECT"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0365","first-page":"6","article-title":"Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.J","volume":"64","author":"Stahl","year":"2003","journal-title":"Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb1365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jad.2012.05.022","article-title":"The relevance of oxidative stress status in first episode and recurrent depression.","volume":"143","author":"Stefanescu","year":"2012","journal-title":"J. Affect. Disorders."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2012.01.018","article-title":"Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder","volume":"510","author":"Talarowska","year":"2012","journal-title":"Neuro. Sci. Lett."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0375","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s11064-012-0788-z","article-title":"Total antioxidant status correlates with cognitive impairment in patients with reccurent depressive disorder","volume":"37","author":"Talarowska","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0380","first-page":"5359","article-title":"Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder","volume":"39","author":"Talarowska","year":"2012","journal-title":"Mol. Biol."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0385","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s11064-010-0172-9","article-title":"Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy","volume":"35","author":"Tasset","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0390","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0006-3223(99)00031-1","article-title":"Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold","volume":"45","author":"Triggs","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2013.09.012","article-title":"Cognitive dysfunction in unipolar depression: implications for treatment","volume":"152","author":"Trivedi","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0400","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4088\/JCP.v69n0211","article-title":"Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression","volume":"69","author":"Trivedi","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0405","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neures.2006.05.012","article-title":"Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes","volume":"56","author":"T\u00fanez","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YCT.0000000000000096","article-title":"No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression","volume":"30","author":"Wajdik","year":"2014","journal-title":"J. ECT."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00165","article-title":"Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder","volume":"4","author":"Wall","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0420","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","article-title":"Increased levels of 4- hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease","volume":"27","author":"Williams","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0425","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.0924-2708.2004.00090.x","article-title":"The relationship between potency of oxidative stress and severity of depression","volume":"16","author":"Yanik","year":"2004","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0430","first-page":"114","article-title":"Hamilton Anxiety Rating Scale, Interrater reliability and validity study","volume":"9","author":"Yazici","year":"1998","journal-title":"Turkish J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-931542","article-title":"High frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors","volume":"39","author":"Yukimasa","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2005.12.029","article-title":"Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients","volume":"91","author":"Zanardini","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0445","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2009.05.016","article-title":"The novel oxidative stress marker thioredoxin is increased in first episode schizophrenic patients","volume":"113","author":"Zhang","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0450","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.schres.2012.11.017","article-title":"Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls","volume":"143","author":"Zhang","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.04.025_bb0455","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijdevneu.2014.11.007","article-title":"Thioredoxin: a novel, independent diagnosis marker in children with autism","volume":"40","author":"Zhang","year":"2015","journal-title":"Int. J. Dev. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630464X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630464X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T13:04:57Z","timestamp":1569071097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461630464X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":91,"alternative-id":["S027858461630464X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.025","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: An rTMS study","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}